Effects of selenium on electrophysiological changes associated with diabetic peripheral neuropathy

Neural Regeneration Research

Volumn 6, Issue 8, 2011, Pages 617-622

  Ayaz, Murat ^a   Kaptan, Hülagu ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

Conduction velocity distribution; Diabetic neuropathy; Sciatic nerve; So dium selenite; Streptozotocin

Indexed keywords

SODIUM CHLORIDE; SODIUM SELENITE;

ACTION POTENTIAL; ANALYTICAL PARAMETERS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONAXY; COMPOUND ACTION POTENTIAL; CONTROLLED STUDY; DIABETIC NEUROPATHY; DRUG EFFICACY; MALE; NERVE CELL MEMBRANE STEADY POTENTIAL; NERVE CONDUCTION; NERVE FIBER; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NEUROPROTECTION; NONHUMAN; RAT; RHEOBASE; SCIATIC NERVE; STREPTOZOCIN DIABETES;

EID: 79955386619     PISSN: 16735374     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1673-5374.2011.08.006     Document Type: Article

References (29)

1. Vinik AI, Park TS, Stansberry KB, et al. Diabetic neuropathies. Diabetologia. 2000;43:957-973
2. Ayad H. Diabetic neuropathy: classification, clinical manifestations, diagnosis and management. In: Baba S, et al, eds. Diabetes Mellitus in Asia. Amsterdam: Excerpta Medica. 1977:222-224.
3. Ayaz M, Tuncer S, Okudan N, et al. Coenzyme Q(10) and alpha-lipoic acid supplementation in diabetic rats: conduction velocity distributions. Methods Find Exp Clin Pharmacol. 2008; 30:367-374.
4. Feldman EL, Stevens MJ, Russell JW, et al. Diabetic neuropathy. In principles and practice of endocrinology and metabolism. In: Becker KL, ed. Pennsylvania. USA: Lippincott Williams & Wilkins. 2001:1391-1399.
5. Rodrigues Filho OA, Fazan VP. Streptozotocin induced diabetes as a model of phrenic nerve neuropathy in rats. J Neurosci Methods. 2006;151:131-138.
6. Van Dam PS, Van Asbeck BS, Erkelens DW, et al. The role of oxidative stress in neuropathy and other diabetic complications. Diabetes/metab Res Rev. 1995;11:181-192.
7. Van Dam PS, Bravenboer B. Oxidative stress and antioxidant treatment in diabetic neuropathy. Neurosci Res Commun. 1997; 21:41-48.
8. Greene DA, Stevens MJ, Obrosova I, et al. Glucoseinduced oxidative stress and programmed cell death in diabetic neuropathy. Eur J Pharmacol. 1999;375:217-223.
9. Feldman EL. Oxidative stress and diabetic neuropathy: a new understanding of an old problem. J Clin Investig. 2003;111: 431-433.
10. Ayaz M, Ozdemir S, Ugur M, et al. Effects of selenium on altered mechanical and electrical cardiac activities of diabetic rat. Arch Biochem Biophys. 2004;426:83-90.
11. Tamborlane WV, Ahern J. Implications and results of the Diabetes Control and Complications Trial. Pediatr Clin North Am. 1997;44: 285-300.
12. Stadtman TC. Selenocysteine. Annu Rev Biochem. 1996;65: 83-100.
13. Behn D, Weiss-Nowak C, Kalcklösch M, et al. Studies on the distribution and characteristics of new mammalian selenium-containing proteins. Analyst. 1995;120:823-825.
14. Rotruck JT, Pope AL, Ganther HE, et al. Selenium: biochemical role as a component of glutathione peroxidase. Science. 1973; 179:588-590.
15. Hopf HC. Studies on the difference in the conductivity rate of motor nerve fibers in man. Deutsche Zeitschrift fiir Nervenheilkunde. 1962;183:579-588.
16. Harayama H, Shinozawa K, Kondo H, et al. A new method to measure the distribution of motor conduction velocity in man. Electroencephalogr Clin Neurophysiol. 1991;81:323-331.
17. Bleys J, Navas-Acien A, Guallar E. Serum selenium and diabetes in U.S. adults. Diabetes Care. 2007;30(4):829-834.
18. Scandalios JG. Oxidative stress response-what genome scale-studies taught us? Genome Biol. 2002;3:1-6.
19. DiMauro S, Schon EA. Mitochondrial respiratory-chain diseases. N Engl J Med. 2003;348:2656-2668.
20. Obrosova IG, Fathallah L, Stevens MJ. Taurine counteracts oxidative stress and nerve growth factor deficit in early experimental diabetic neuropathy. Exp Neurol. 2001;172:211-219.
21. Cameron NE, Eaton SE, Cotter MA, et al. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia. 2001;44:1973-1988.
22. Greene DA, Obrosova I, Stevens MJ, et al. Pathways of glucose-mediated oxidative stress in diabetic neuropathy. In: Packer L, Rosen P, Tritschler HJ, King GL, Azzi A, eds. Antioxidants in Diabetes Management. New York, USA: Marcel Dekker Inc. 2000:111-119.
23. Low PA, Nickander KK, Tritschler HJ. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes. 1997;46:S38-42.
24. Tomlinson DR. Future prevention and treatment of diabetic neuropathy. Diabetes Metab. 1998;24:79-83.
25. Cameron NE, Cotter MA. Metabolic and vascular factors in the pathogenesis of diabetic neuropathy. Diabetes. 1997;46:S31-37.
26. van Dam PS, Bravenboer B. Oxidative stress and antioxidant treatment in diabetic neuropathy. Neurosci Res Commun. 1997; 21:41-48.
27. Greene DA, Stevens MJ, Obrosova I, et al. Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy. Eur J Pharmacol. 1999;375:217-223.
28. Ayaz M, Celik HA, Aydin HH, et al. Sodium selenite protects against diabetes-induced alterations in the antioxidant defense system of the liver. Diabetes Metab Res Rev. 2006;22:295-299.
29. Ayaz M, Turan B. Selenium prevents diabetes-induced alterations in [Zn2+]i and metallothionein level of rat heart via restoration of cell redox cycle. Am J Physiol Heart Circ Physiol. 2006;290: H1071-1080.